cancer-immunotherapy

Documents about cancer-immunotherapy

• CCCR-NK92 Cells Immunotherapy for Non-small Cell Lung Carcinoma#346917ClinicalTrials.gov
• Follow the “DOTs”: Vδ1(+) γδ T cells as effectors of cancer immunotherapy#360966PubMed Central
• Testing Immunotherapy for Patients With Liver Cancer and Moderately Altered Liver Functions#394751ClinicalTrials.gov
• E7 TCR T Cell Immunotherapy for High-Grade Cervical Intraepithelial Neoplasia#407732ClinicalTrials.gov
• Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma#414491ClinicalTrials.gov
• ASIA Study : French Register of Inflammatory Eye Disease#414503ClinicalTrials.gov
• Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy#414960HAL (France)
• Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC#432876ClinicalTrials.gov
• Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma#442076ClinicalTrials.gov
• Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies.#442104ClinicalTrials.gov
• Psychological distress as a putative host-state determinant of cancer immunotherapy response.#455120NCBI PubMed Central
• Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.#457464NCBI PubMed Central
• Neural regulation of tumor immunity: emerging opportunities to enhance cancer immunotherapy.#645449NCBI PubMed Central
• Image 4_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tiff#442373Figshare
• Image 3_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tiff#442374Figshare
• Image 5_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tif#442375Figshare
• Image 6_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tif#442376Figshare
• Table 1_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.docx#442377Figshare
• Image 1_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tif#442378Figshare
• Image 2_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tif#442379Figshare
• Harnessing the NKG2D immune surveillance pathway using engineered T-cells for the treatment of human disease#4654Europe PMC
• Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative Group#630580IRIS
• A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC#121331ClinicalTrials.gov
• Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer#230404ClinicalTrials.gov
• Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors#394761ClinicalTrials.gov
• Rationale and Design of the Cancer Immunotherapy Evidence Living (CIEL) Library: A Continuously Updated Clinical Trial Database of Cancer Immunotherapies.#30627NCBI PubMed Central
• The Effect of Chronic Stress on Efficacy of ICIs in Esophageal Cancer Patients (STRESS-ESCA Study)#67898ClinicalTrials.gov
• Orem's Self-Care Deficit Theory Based Nursing Interventions for Immunotherapy Treated Cancer Patients#160357ClinicalTrials.gov
• PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer#253000ClinicalTrials.gov
• A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC)#256884ClinicalTrials.gov
• Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy#272351ClinicalTrials.gov
• Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer#311132ClinicalTrials.gov
• Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer#314337ClinicalTrials.gov
• Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy#356476ClinicalTrials.gov
• Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer#448255ClinicalTrials.gov
• Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome#454009ClinicalTrials.gov
• Postoperative Management for HNSCC Based on Pathological Response of Induction Chemotherapy and Immunotherapy#623511ClinicalTrials.gov
• Immune Response to COVID-19 Vaccine in Immunotherapy (IO) and Non-IO Treated Cancer Patients#860934ClinicalTrials.gov
• Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer#862471ClinicalTrials.gov
• Oral, Fecal and Intratumoral Microbiome Atlas in Colombian Patients With Advanced Solid Tumors Receiving First-Line Immunotherapy#442099ClinicalTrials.gov
• Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer#849696ClinicalTrials.gov
• A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies#849810ClinicalTrials.gov
• Next-generation neoantigen mRNA vaccines: Immuno-engineering strategies for precision cancer immunotherapy.#25589NCBI PubMed Central
• Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers#28341ClinicalTrials.gov
• Feasibility of a Lifestyle Intervention for Women With Triple-negative Breast Cancer Under Neoadjuvant Immunotherapy#154643ClinicalTrials.gov
• Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic Disease#172285ClinicalTrials.gov
• Pan-cancer survival modeling reveals structural limits of genomic feature integration in immunotherapy outcomes#192317bioRxiv / medRxiv
• Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)#256885ClinicalTrials.gov
• Immunotherapy in Patient With Poor General Condition#256903ClinicalTrials.gov
• Cardiovascular Effects of CART Cell Therapy#300244ClinicalTrials.gov